Table 1.

Characteristics of patients

^*consisted of 5 rheumatoid arthritis, 5 multiple sclerosis, 1 systemic lupus erythematosus; ^†, consisted of myelofibrosis and non-Hodgkin's lymphoma; ^‡, Analysis excluding 9 patients who died before engraftment.

AML, acute myelogenous leukemia; ALL, acute lymphocytic leukemia; CML, chronic myelogenous leukemia; SAA, severe aplastic anemia; MDS, myelodysplastic syndrome; MM, multiple myeloma; ABL, acute biphenotype leukemia; BM, bone marrow; PB, peripheral blood; TBI, total body irradiation; MDS, matched sibling donor; MUD, matched unrelated donor; FMM, family mismatched; NST, non-myeloablative stem cell transplantation; CsA, cyclosporin A; MTX, methotrexate; FK506, tacrolimus; GVHD, graft versus host disease.